Using TGF-β1 less than or equal to 39.9 ng/mL and angiopoietin-2 > 1008 pg/mL as a cutoff, non-CCA cases were identified and 100% correctly classified. This evidence concerns the gene ANGPT2 and cholangiocarcinoma.